Russell Cox
Director/Board Member at GOSSAMER BIO, INC.
Net worth: 13 916 $ as of 2024-04-29
Profile
Russell J.
Cox is currently the President & Chief Executive Officer at Epirium Bio, Inc., the Director at Vascular Cures, and an Independent Director at Gossamer Bio, Inc. Previously, he served as the Chief Executive Officer & Director at Vital Therapies, Inc., the Co-Chief Executive Officer & Director at Immunic, Inc., the Chairman at Spyre Therapeutics, Inc., and the Group Product Manager at Genentech, Inc. He also held positions as the Vice President-Marketing at Scios, Inc. and Tercica, Inc., the Chief Commercial Officer & EVP at Jazz Pharmaceuticals, Inc., and the Chief Commercial Officer & Senior Vice President at Ipsen, Inc. Additionally, he served as the Chief Operating Officer & Executive Vice President at Jazz Pharmaceuticals Plc.
Mr. Cox obtained his undergraduate degree from Texas A&M University in 1985.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SPYRE THERAPEUTICS, INC
0.00% | 2024-02-14 | 280 ( 0.00% ) | 9 092 $ | 2024-04-29 |
GOSSAMER BIO, INC.
0.00% | 2024-04-15 | 7,200 ( 0.00% ) | 4 824 $ | 2024-04-29 |
Russell Cox active positions
| Companies | Position | Start |
|---|---|---|
| GOSSAMER BIO, INC. | Director/Board Member | 2018-12-18 |
Vascular Cures
 Vascular Cures Miscellaneous Commercial ServicesCommercial Services Vascular Cures is a voluntary health organization that operates to improve the lives of individuals affected by vascular diseases. Vascular Cures is based in Redwood City, CA. The non-profit company's focus is on advancing research, education, and awareness of vascular diseases. The CEO of the company is Wendy R. Hitchcock. | Director/Board Member | 2012-12-31 |
Epirium Bio, Inc.
 Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Epirium Bio, Inc. develops therapeutics for orphan and rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems. The company was founded in 2008 by Alan Stewart Maisel, Sundeep Dugar, and Francisco Villarreal and is headquartered in Los Altos Hills, CA. | Chief Executive Officer | 2019-05-31 |
Former positions of Russell Cox
| Companies | Position | End |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Chairman | 2024-05-12 |
Vital Therapies, Inc.
 Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Chief Executive Officer | 2019-01-24 |
| IMMUNIC, INC. | Chief Executive Officer | 2018-12-31 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Chief Operating Officer | 2018-01-02 |
| JAZZ PHARMACEUTICALS PLC | Chief Operating Officer | 2018-01-02 |
Training of Russell Cox
| Texas A&M University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| SPYRE THERAPEUTICS, INC. | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| IMMUNIC, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Vascular Cures
Vascular Cures Miscellaneous Commercial ServicesCommercial Services Vascular Cures is a voluntary health organization that operates to improve the lives of individuals affected by vascular diseases. Vascular Cures is based in Redwood City, CA. The non-profit company's focus is on advancing research, education, and awareness of vascular diseases. The CEO of the company is Wendy R. Hitchcock. | Commercial Services |
Ipsen, Inc.
 Ipsen, Inc. Industrial MachineryProducer Manufacturing Ipsen, Inc. design and manufacture of industrial atmosphere and vacuum heat-treating systems and supervisory controls systems. It offers vacuum furnaces, atmosphere furnaces, and PdMetrics software platform. The company was founded by Harold Ipsen in 1948 and is headquartered in Cherry Valley, IL. | Producer Manufacturing |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Health Technology |
Epirium Bio, Inc.
Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Epirium Bio, Inc. develops therapeutics for orphan and rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems. The company was founded in 2008 by Alan Stewart Maisel, Sundeep Dugar, and Francisco Villarreal and is headquartered in Los Altos Hills, CA. | Health Technology |
- Stock Market
- Insiders
- Russell Cox
